Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oxigene signs agreement for combretastatin development

May 29, 1997

Vital to develop anticancer drug

May 29, 1997

Activated Cell Therapy's immunotherapy for prostate cancer enters clinic

May 29, 1997

Hayashibara discloses potent, broad-spectrum antitumor agents

May 29, 1997

Prodrugs of nitrogen mustard with selective antitumor activity

May 27, 1997

Natural antitumor compounds described by Banyu

May 27, 1997

Inhibitors of 5alpha-reductase from Kyowa Hakko

May 27, 1997

Banyu discovers potent new antitumor agent

May 27, 1997

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

May 27, 1997

Panretin in AIDS-related Kaposi's sarcoma

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...